Mindfulness in chest pain (MIPIC)
Research type
Research Study
Full title
Mindfulness based intervention in patients with persistent pain in chest (MIPIC) of non-cardiac cause - a feasibility randomised control study.
IRAS ID
253106
Contact name
Tarun Kumar Mittal
Contact email
Sponsor organisation
Royal Brompton and Harefield NHS Foundation Trust
Duration of Study in the UK
0 years, 11 months, 30 days
Research summary
Background
Non-acute or stable chest pain is a common symptom in general practice (GP). However, almost 80% of patients are not found to have a heart condition that is responsible for their chest pain and are treated for muscular or bony pain, heartburn, or a psychological cause. A proportion of these patients continue to have persistent chest pain that can result in individual suffering, impaired quality of life, and frequent visits to GPs and A & Es.Over the past several years, mindfulness has emerged as a recognised technique for reducing stress and preventing repeated episodes of depression. Although its use has been studied in chronic pain in other disorders, there is no study of its use in stable chest pain.
Aim of the research
We plan to perform a feasibility study with the aim to identify the number of patients who continue to suffer from chest pain after a heart condition has been excluded and are willing to participate in a mindfulness programme of 8-weeks. We will also like to develop an adaptation of mindfulness for chest pain and assess its compliance. Obtaining these parameters will help us in planning the main randomised controlled trial to evaluate the effectiveness of mindfulness in reducing the perception of chest pain.Design and Methods
The study will recruit 50 eligible patients who attended the chest pain clinic at Harefield Hospital in last 12 months. We would assign half the patients to mindfulness therapy with usual care (intervention arm) and the other half to usual care alone (control arm). Mindfulness therapy will be given by experienced teachers in 2.5 hours-weekly sessions for 8-weeks in groups of up to 15 patients. The usual-care group may or may not be on any treatment by their GP. Patients in both groups will be followed-up at 2 to 3-months to assess compliance with the programme.REC name
London - Riverside Research Ethics Committee
REC reference
19/LO/1092
Date of REC Opinion
22 Aug 2019
REC opinion
Further Information Favourable Opinion